口服避孕药与宫内节育器使用与宫颈上皮内瘤变III级或更严重病变风险:一项基于人群的研究
该回顾性人群队列研究纳入2005至2009年宫颈癌筛查细胞学正常的29-44岁女性702,037例,中位随访9.7年,比较口服避孕药(OC)或宫内节育器(IUD)至少5年注册使用与非使用者的CIN3+风险。结果显示IUD使用与CIN3+风险升高相关(RR 1.51),OC使用与CIN3+(RR 2.77)及宫颈癌(RR 2.06)风险升高相关,且OC使用者风险高于IUD使用者。
要点
- OC使用与CIN3+及宫颈癌风险升高相关,且风险高于IUD使用者。
- IUD使用亦与CIN3+风险升高相关,但幅度低于OC。
- 有避孕需求女性中,IUD可能较OC更安全。
核心结论
- OC使用和IUD使用均与CIN3+风险升高相关,但OC使用者发生CIN3+和宫颈癌的风险高于IUD使用者。
研究设计与样本
- 回顾性人群队列研究,纳入2005至2009年荷兰病理登记中参加宫颈癌筛查且细胞学正常的29-44岁女性702,037例,中位随访9.7年。
主要发现
- 702,037例女性中,6,705例(0.96%)发生CIN3,559例(0.08%)发生宫颈癌。
- IUD使用与CIN3+风险升高相关(RR 1.51,95%CI 1.32-1.74)。
- OC使用与CIN3+风险升高相关(RR 2.77,95%CI 2.65-3.00)及宫颈癌风险升高相关(RR 2.06,95%CI 1.52-2.79)。
- OC使用者较IUD使用者CIN3+风险更高(RR 1.83,95%CI 1.60-2.09),宫颈癌风险亦更高(RR 1.70,95%CI 1.00-2.90)。
临床怎么用
- 对有避孕需求的女性,可考虑将IUD作为较OC更安全的避孕选择,以降低CIN3+及宫颈癌风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Hormonal contraceptive use has been associated with the development of cervical cancer, although inconsistent results are reported on the association with intrauterine device (IUD) use. The aim of this study was to evaluate the association between the type of contraceptive use and the development of cervical intraepithelial neoplasia grade III or worse (CIN3+). METHODS: A retrospective population-based cohort study including women aged 29-44 years attending the cervical cancer screening program with normal cytology between 2005 and 2009 identified from the Dutch Pathology Registry. Subgroups with at least 5 years registered use of an oral contraceptive (OC) or IUD were compared with non-users. Risk ratios of CIN3+ were estimated per contraceptive type. RESULTS: 702,037 women were included with a median follow-up of 9.7 years, of which 6705 (0.96%) and 559 (0.08%) women developed CIN3 and cervical cancer, respectively. IUD use was associated with an increased risk of developing CIN3+ (risk ratio (RR) 1.51, 95% confidence interval (CI) 1.32-1.74), and OC use was associated with an increased risk of developing CIN3+ (RR 2.77, 95%CI 2.65-3.00) and cervical cancer (RR 2.06, 95%CI 1.52-2.79). The risk of developing CIN3+ and cervical cancer was higher for OC users compared with IUD users (RR 1.83, 95%CI 1.60-2.09 and RR 1.70, 95%CI 1.00-2.90, respectively). CONCLUSIONS: Both OC use and IUD use were associated with an increased risk of developing CIN3+. However, for women with a contraceptive wish, an IUD seems safer than an OC as the risk of developing CIN3+ and cervical cancer was higher for OC users.
引用
- Loopik DL, IntHout J, Melchers WJG, et al. Oral contraceptive and intrauterine device use and the risk of cervical intraepithelial neoplasia grade III or worse: a population-based study. Eur J Cancer. 2019. PMID: 31760309. doi:10.1016/j.ejca.2019.10.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。